What does TOBUFAR do?

TOBUFAR is registered with the CBE as active in: Groothandel in farmaceutische producten. Private Limited, started on 30 October 1998, 1 establishment.

What is the address of TOBUFAR?

The registered office of TOBUFAR is located at Joseph Bensstraat 83A, 1180 Ukkel.

Is TOBUFAR still active?

Yes. According to the CBE (31 October 2026) TOBUFAR is active, legal situation “Normale toestand”, started on 30 October 1998.

Is TOBUFAR registered on Peppol?

Yes, TOBUFAR is registered on the Peppol network with ID 0208:0464486973.

What is the enterprise number of TOBUFAR?

The enterprise number of TOBUFAR is BE0464486973.

When was TOBUFAR founded?

TOBUFAR was founded on 30 October 1998.

Who are the directors of TOBUFAR?

According to the 2025 annual accounts, the directors of TOBUFAR are: MEDCOLAB.

Is TOBUFAR a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 30 October 1998; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did TOBUFAR make in 2025?

TOBUFAR posted a profit after taxes of € 380,924 in financial year 2025.

What is the revenue of TOBUFAR?

In its most recent annual accounts (2025), TOBUFAR reported revenue of € 12,124,022.

How much does an employee at TOBUFAR earn?

The average wage cost per full-time employee at TOBUFAR was € 54,200 in 2025: staff costs of € 151,623 for 2.8 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does TOBUFAR have?

According to the 2025 annual accounts, TOBUFAR has 2.8 full-time equivalents (FTE).

TOBUFAR (Private Limited) - Ukkel - BE0464486973

Dossier TOBUFAR, printed on 31 October 2026 from databakkes.be/en/0464486973/tobufar. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

TOBUFAR from Ukkel, company number BE0464486973, closed financial year 2025 with a result of € 380,924 after tax. For that financial year TOBUFAR recorded revenue of € 12.1 million and equity of € 5.8 million. Compared with financial year 2024, the result moved from € 315,262 to € 380,924. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 12, 2026.

What it is worth Growing

€ 5.8 million

▲ 7% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 380,924

▲ 21% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 745,653

▼ 6% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 5.7 million.

People and assets in 2025

Full-time equivalents

2.8

▲ 0.5 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost Staff costs are payroll only. Director pay sits with services and miscellaneous goods: € 395,588 in 2025, together with rent, insurance, accountants and other services. The accounts do not split that further.

€ 151,623

▲ 18% vs 2024

€ 54,200 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 4,722

▼ 88% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 4,245

▼ 73% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 843,369

▼ 17% vs 2024

Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 27 days on average.

Taxes and wages

€ 19,643

▲ 38% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Revenue	€ 14,129,066 Revenue 2022: € 14,129,066 First fiscal year in the series	€ 14,031,150 Revenue 2023: € 14,031,150 ▼ 1% vs 2022 (€ 14,129,066) Unfavourable step	-	€ 12,124,022 Revenue 2025: € 12,124,022 First fiscal year in the series
Gross margin	-	-	€ 650,536 Gross margin 2024: € 650,536 First fiscal year in the series	-
Profit after taxes	€ 478,554 Profit after taxes 2022: € 478,554 First fiscal year in the series	€ 400,883 Profit after taxes 2023: € 400,883 ▼ 16% vs 2022 (€ 478,554) Unfavourable step	€ 315,262 Profit after taxes 2024: € 315,262 ▼ 21% vs 2023 (€ 400,883) Unfavourable step	€ 380,924 Profit after taxes 2025: € 380,924 ▲ 21% vs 2024 (€ 315,262) Favourable step	▲ 21%
Equity	€ 5,237,770 Equity 2022: € 5,237,770 First fiscal year in the series	€ 5,350,687 Equity 2023: € 5,350,687 ▲ 2% vs 2022 (€ 5,237,770) Favourable step	€ 5,404,067 Equity 2024: € 5,404,067 ▲ 1% vs 2023 (€ 5,350,687) Favourable step	€ 5,784,991 Equity 2025: € 5,784,991 ▲ 7% vs 2024 (€ 5,404,067) Favourable step	▲ 7%
Total debts	€ 1,185,397 Total debts 2022: € 1,185,397 First fiscal year in the series	€ 1,866,245 Total debts 2023: € 1,866,245 ▲ 57% vs 2022 (€ 1,185,397) Unfavourable step	€ 1,362,240 Total debts 2024: € 1,362,240 ▼ 27% vs 2023 (€ 1,866,245) Favourable step	€ 1,712,124 Total debts 2025: € 1,712,124 ▲ 26% vs 2024 (€ 1,362,240) Unfavourable step	▲ 26%
Cash	€ 680,151 Cash 2022: € 680,151 First fiscal year in the series	€ 758,610 Cash 2023: € 758,610 ▲ 12% vs 2022 (€ 680,151) Favourable step	€ 794,146 Cash 2024: € 794,146 ▲ 5% vs 2023 (€ 758,610) Favourable step	€ 745,653 Cash 2025: € 745,653 ▼ 6% vs 2024 (€ 794,146) Unfavourable step	▼ 6%
Land & buildings	€ 1,155,142 Land & buildings 2022: € 1,155,142 First fiscal year in the series	€ 1,102,447 Land & buildings 2023: € 1,102,447 ▼ 5% vs 2022 (€ 1,155,142) Unchanged	€ 1,040,120 Land & buildings 2024: € 1,040,120 ▼ 6% vs 2023 (€ 1,102,447) Unchanged	€ 987,896 Land & buildings 2025: € 987,896 ▼ 5% vs 2024 (€ 1,040,120) Unchanged	▼ 5%
Retained profit	€ 5,200,586 Retained profit 2022: € 5,200,586 First fiscal year in the series	€ 5,313,503 Retained profit 2023: € 5,313,503 ▲ 2% vs 2022 (€ 5,200,586) Favourable step	€ 5,366,883 Retained profit 2024: € 5,366,883 ▲ 1% vs 2023 (€ 5,313,503) Favourable step	€ 5,747,807 Retained profit 2025: € 5,747,807 ▲ 7% vs 2024 (€ 5,366,883) Favourable step	▲ 7%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 287,966 Dividend 2023: € 287,966 Unchanged (€ 0) Unchanged	€ 261,882 Dividend 2024: € 261,882 ▼ 9% vs 2023 (€ 287,966) Unchanged	€ 0 Dividend 2025: € 0 ▼ 100% vs 2024 (€ 261,882) Unchanged	▼ 100%
Bank debt	€ 50,950 Bank debt 2022: € 50,950 First fiscal year in the series	€ 36,015 Bank debt 2023: € 36,015 ▼ 29% vs 2022 (€ 50,950) Favourable step	€ 15,492 Bank debt 2024: € 15,492 ▼ 57% vs 2023 (€ 36,015) Favourable step	€ 4,245 Bank debt 2025: € 4,245 ▼ 73% vs 2024 (€ 15,492) Favourable step	▼ 73%
Balance sheet total	€ 6,426,173 Balance sheet total 2022: € 6,426,173 First fiscal year in the series	€ 7,219,590 Balance sheet total 2023: € 7,219,590 ▲ 12% vs 2022 (€ 6,426,173) Unchanged	€ 6,768,638 Balance sheet total 2024: € 6,768,638 ▼ 6% vs 2023 (€ 7,219,590) Unchanged	€ 7,499,119 Balance sheet total 2025: € 7,499,119 ▲ 11% vs 2024 (€ 6,768,638) Unchanged	▲ 11%
Employees (FTE)	2.2 Employees (FTE) 2022: 2.2 First fiscal year in the series	2.2 Employees (FTE) 2023: 2.2 Unchanged (2.2) Unchanged	2.3 Employees (FTE) 2024: 2.3 ▲ 0.1 vs 2023 (2.2) Unchanged	2.8 Employees (FTE) 2025: 2.8 ▲ 0.5 vs 2024 (2.3) Unchanged	▲ 0.5

Key figures of TOBUFAR, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to TOBUFAR?

What happened at TOBUFAR in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 12, 2026 New annual accounts for financial year 2025: profit of € 380,924 (▲ 21% vs 2024). Source: NBB ↗
2011 MEDCOLAB became a director. NBB
Nov 2, 1998 New establishment in Sint-Genesius-Rode. KBO
Oct 30, 1998 Start of the company according to the CBE. KBO

In short

From € 478,554 profit in 2022 to € 380,924 profit in 2025.

Paid € 581,366 in corporate taxes since 2022.

Best year ever: 2022, with € 478,554 profit.

On average € 282,800 of value added per employee in 2024.

Original PDFs at the National Bank ↗

Management

William Vandenbulcke 20%

Julien Vandenbulcke 20%

Antoon Vandenbulcke 20%

Charlotte Vandenbulcke 20%

TOBUFAR

Behind TOBUFAR is MEDCOLAB. The shares are held by William Vandenbulcke (20%), Julien Vandenbulcke (20%), Antoon Vandenbulcke (20%), Charlotte Vandenbulcke (20%) and Olivia Vandenbulcke (20%).

Directors

According to the 2025 annual accounts

MEDCOLAB

Director · represented by Antoon Vandenbulcke

since 2011

Shareholders

William Vandenbulcke

20%

Julien Vandenbulcke

20%

Antoon Vandenbulcke

20%

Charlotte Vandenbulcke

20%

Olivia Vandenbulcke

20%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Joseph Bensstraat 83A

1180 Ukkel

2.089.060.096

Hallesesteenweg 156

1640 Sint-Genesius-Rode

Active since 2 November 1998

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

JC PHARMA

€ 325,114 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0464.486.973

VAT number

BE 0464.486.973

Registered office

Joseph Bensstraat 83A, 1180 Ukkel

Names & denominations

TOBUFAR

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

30 October 1998

Peppol

Active · Active since 13 Jan 2026

Activities · NACE

Groothandel in farmaceutische producten

Groothandel in farmaceutische en medische artikelen

View on CBE Public ↗ Annual accounts (NBB) ↗

TOBUFAR

Financials

What happened to TOBUFAR?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions